ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2021

Denosumab is not associated with risk of malignancy? More evidence is needed.

J Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.